# Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results

> **NCT04060485** · — · UNKNOWN · sponsor: **National Taiwan University Hospital** · enrollment: 1000 (estimated)

## Conditions studied

- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- Myeloproliferative Neoplasm
- Aplastic Anemia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04060485
- **Lead sponsor:** National Taiwan University Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-08-19
- **Primary completion:** 2024-08-31
- **Final completion:** 2024-12-31
- **Target enrollment:** 1000 (ESTIMATED)
- **Last updated:** 2019-08-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04060485

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04060485, "Screening Gene Mutations in Myeloid Cancers by Next Generation Sequencing to Improve Treatment Results". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04060485. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*